Khon Kaen University

Kutatók

• WLWatcharin Loilome

Futó vizsgálatok

• Még nem toboroz

  An AI-Based Erythema Measurement System for Psoriasis Lesions

  NCT07494396· Khon Kaen University· Forrás

• Még nem toboroz

  Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II

  NCT07513623· 2. fázis· University of California, San Francisco· Forrás

• Toboroz

  Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma

  NCT07245238· 3. fázis· Khon Kaen University· Forrás

• Toboroz

  A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  NCT06952504· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Meghívásos bevonás

  Efficacy of Topical Cannabidiol for Eczema

  NCT06994520· 2. fázis· Khon Kaen University· Forrás

• Toboroz

  Postoperative Atrial Fibrillation in Cardiac Surgery

  NCT06958029· Khon Kaen University· Forrás

• Toboroz

  A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

  NCT06841354· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

  NCT06337032· 4. fázis· Gilead Sciences· Forrás

• Fut, nem toboroz

  A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

  NCT06455202· 3. fázis· Celldex Therapeutics· Forrás

• Toboroz

  Evaluating a Community-Based Behaviour Change Communication Model to Prevent Cholangiocarcinoma in Khon Kaen, Thailand

  NCT05321992· McMaster University· Forrás

• Toboroz

  COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2

  NCT06396299· Mahidol University· Forrás

• Fut, nem toboroz

  A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

  NCT06097364· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Fut, nem toboroz

  Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

  NCT06074588· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Meghívásos bevonás

  A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

  NCT05979441· 3. fázis· argenx· Forrás

• Toboroz

  A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

  NCT05744921· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Fut, nem toboroz

  Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

  NCT05462717· 1. fázis· Revolution Medicines, Inc.· Forrás

• Fut, nem toboroz

  LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321420· 2. fázis· PureTech· Forrás

• Fut, nem toboroz

  Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

  NCT05248646· 3. fázis· Otsuka Pharmaceutical Development & Commercialization, Inc.· Forrás

• Toboroz

  Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

  NCT04375800· 2. fázis· Merck Sharp & Dohme LLC· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Pitvarfibrilláció2 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Cytomegalovirus infection1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• HIV-fertőzés1 toboroz
• Máj- és epeúti rák1 toboroz
• Méhtestrák1 toboroz
• Pikkelysömör1 toboroz
• Stroke (szélütés)1 toboroz
• Szisztémás szklerózis (szkleroderma)1 toboroz
• Tripla negatív emlőrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  Self-management Telehealth Program for Scleroderma

  NCT06990386· Khon Kaen University· Forrás

• Lezárult

  Effectiveness of Cannabinoids on Appetite in Scleroderma

  NCT05416697· 3. fázis· Khon Kaen University· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· 2/3. fázis· argenx· Forrás

• Lezárult

  A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment

  NCT05133531· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Leállították

  Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes

  NCT03586284· 2/3. fázis· University of California, San Francisco· Forrás

• Lezárult

  Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children

  NCT01854775· 2/3. fázis· Gilead Sciences· Forrás

• Lezárult

  A Prospective Cohort of Children With HIV Infection

  NCT00476606· The HIV Netherlands Australia Thailand Research Collaboration· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Máj- és epeúti rák91 munka · 1 vizsgálat
• Szisztémás szklerózis (szkleroderma)19 munka · 3 vizsgálat
• Thalassaemia19 munka · 0 vizsgálat